Christopher J Layton (C J Layton)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Ankylosing Spondylitis

Top Venues

Expert reviews in molecular medicine

Clinical & experimental ophthalmology

Journal of ophthalmology

This page only lists publications with an associated author ORCID identifier.

Publications

Brenda F M Castro, Jason C Steel, Christopher J Layton
AAV-mediated gene therapies for glaucoma and uveitis: are we there yet? Expert reviews in molecular medicine 26 (2024)
Brenda F M Castro, Jason C Steel, Christopher J Layton
AAV-mediated gene therapies for glaucoma and uveitis: are we there yet? Expert reviews in molecular medicine 26 (2024)
Brenda F M Castro, Jason C Steel, Christopher J Layton
AAV-mediated gene therapies for glaucoma and uveitis: are we there yet? Expert reviews in molecular medicine 26 (2024)
Brenda F M Castro, Jason C Steel, Christopher J Layton
AAV-mediated gene therapies for glaucoma and uveitis: are we there yet? Expert reviews in molecular medicine 26 (2024)
Brenda F M Castro, Jason C Steel, Christopher J Layton
AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Christopher J Layton, Danielle M Layton
Time-to-event survival statistics in ophthalmology: Methodological research. Clinical & experimental ophthalmology 48 (9) (2020)
Sławomir Andrzejewski, Peter Michael Moyle, Brett W Stringer, Jason C Steel, Christopher J Layton
Neutralisation of adeno-associated virus transduction by human vitreous humour. Gene therapy 28 (5) (2020)
Slawomir Andrzejewski, Aparna Murali, Charmaine Ramlogan-Steel, Katie P Edwards, Nathan Efron, Jason C Steel, Christopher J Layton
Adeno-associated virus neutralising antibodies in type 1 diabetes mellitus. Gene therapy 26 (6) (2019)
Charmaine A Ramlogan-Steel, Aparna Murali, Slawomir Andrzejewski, Bijay Dhungel, Jason C Steel, Christopher J Layton
Gene therapy and the adeno-associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations. Clinical & experimental ophthalmology 47 (4) (2019)
P Et Lau, K S Jenkins, Christopher J Layton
Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections. Journal of ophthalmology 2018 (2018)
K Sean Jenkins, Jason C Steel, Christopher J Layton
Systematic Assessment of Clinical Methods to Diagnose and Monitor Diabetic Retinal Neuropathy. Journal of ophthalmology 2018 (2018)
Bijay P Dhungel, Slawomir Andrzejewski, Aparna Jayachandran, Ritu Shrestha, Charmaine A Ramlogan-Steel, Christopher J Layton, Jason C Steel
Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma. Gene therapy 25 (2) (2018)
Aparna Murali, Charmaine A Ramlogan-Steel, Slawomir Andrzejewski, Jason C Steel, Christopher J Layton
Retinal explant culture: A platform to investigate human neuro-retina. Clinical & experimental ophthalmology 47 (2) (2018)